Healthcare & life sciences

Maximizing the rare chance of launch success with orphan drugs

A strategic approach to achieving launch excellence and success for rare-disease medicines

The intelligent pharmaceutical supply chain

Enable a superior patient-and-caregiver experience with a leading-edge digital supply chain

10 %
Share of healthcare industry in global GDP
480 B$
Estimated value of the global biologics market in 2024 (billion USD)
20 %
Year-on-year growth rate of investments in digitalization of the healthcare sector
Challenges
Services
Results